SynthesisDrug design, development and therapy2014

Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials.

Lile Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.